Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Vitamin D may help regulate cholesterol and influence prostate cancer development.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Adipose-derived stem cell exosomes can help reduce skin aging from UV exposure.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Medications can cause eye problems, so regular eye check-ups are important.

Anorexia nervosa causes serious health issues, best treated with a team approach focusing on nutrition.

New drug uses show promise but need more research.

New therapies show promise for wound healing, but more research is needed for safe, affordable options.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

COVID-19 can cause different types of hair loss, with telogen effluvium being the most common.

COVID-19 survivors may face long-term health issues affecting both mind and body.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The model and estimator can predict drug exposure in kidney transplant patients well.

Antioxidants may help improve mitochondrial health and could be used to treat diseases related to cell damage.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Hormonal contraceptives are effective for teens but require careful consideration of side effects and individual health.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

Finasteride may cause long-lasting sexual side effects.

Minoxidil effectively treats severe hypertension but may cause side effects, so careful monitoring is needed.